[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334435-105":59,"doc-detail-334435-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","delineated-3-1-bencarmethinylpro-phosphonic-acids-adroit-activity-against-lung-cancer-through-multitargeted-docking-mm-gbsa-qm-dft-and-multiscale-simulations","Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid’s Adroit Activity against Lung Cancer through Multitargeted Docking, MM-GBSA, QM-DFT and Multiscale Simulations","","Lung cancer remains a pervasive disease with limited treatment options and complex molecular profiles that hinder effective therapy. Because single-target drugs have constrained success due to tumor heterogeneity, multitargeted drug design is used to simultaneously engage key proteins and pathways, aiming to improve efficacy and counter resistance while restraining tumor growth and spread. Docking of DrugBank compounds with HTVS/SP-XP and MM-GBSA scoring identifies 3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1hIndol-5-Yloxy)-Propyl-]-Phosphonic Acid as a candidate, supported by pharmacokinetic and QM-DFT results, interaction fingerprints, and a 100 ns MD simulation showing stable behavior in SPC water, though experimental validation is required.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/delineated-3-1-bencarmethinylpro-phosphonic-acids-adroit-activity-against-lung-cancer-through-multitargeted-docking-mm-gbsa-qm-dft-and-multiscale-simulations/334435/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/delineated-3-1-bencarmethinylpro-phosphonic-acids-adroit-activity-against-lung-cancer-through-multitargeted-docking-mm-gbsa-qm-dft-and-multiscale-simulations/334435.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"Why is multitargeted drug design needed for lung cancer in this study?","Question",{"text":112,"@type":113},"Single-target drugs have limited success because lung cancer is heterogeneous and resists one-size-fits-all treatments. Multitargeting aims to engage multiple proteins and pathways to improve efficacy and overcome resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What computational methods were used to evaluate the candidate drug?",{"text":117,"@type":113},"The study used multitarget docking (HTVS and SP with XP algorithms), MM-GBSA scoring, pharmacokinetic assessment, and QM-based DFT studies, followed by interaction fingerprinting and 100 ns molecular dynamics simulation.",{"name":119,"@type":110,"acceptedAnswer":120},"Which compound is reported as the multitargeted candidate?",{"text":121,"@type":113},"The compound identified as a multitargeted drug candidate is 3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1hIndol-5-Yloxy)-Propyl-]-Phosphonic Acid (3-1-BenCarMethIn YlPro-Phosphonic Acid), listed as DB02504.",{"name":123,"@type":110,"acceptedAnswer":124},"What did the 100 ns MD simulation indicate about stability?",{"text":125,"@type":113},"In SPC water with an NPT ensemble, the simulation showed stable performance with deviation and fluctuations less than 2 Å, supported by strong interactions, suggesting promise for further development despite the need for experimental studies.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},334435,1791450499,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":4},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Article  \nDelineated 3-1-BenCarMethInYlPro-Phosphonic Acid’s Adroit Activity against Lung Cancer through Multitargeted Docking, MM\\GBSA, QM-DFT and Multiscale Simulations  \nMohammed Ageeli Hakami 1, Ali Hazazi 2, Fawaz Albloui 2, Amal F. Gharib 3, Fouzeyyah Ali Alsaeedi 3, Osama Abdulaziz 3, Abdulfattah Y. Alhazmi 4 and Ahad Amer Alsaiari 3, *  \nCitation: Hakami, M.A.; Hazazi, A.; Albloui, F.; Gharib, A.F.; Alsaeedi, F.A.; Abdulaziz, O.; Alhazmi, A.Y.; Alsaiari, A.A. Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid’s Adroit Activity against Lung Cancer through Multitargeted Docking, MM\\GBSA, QM-DFT and Multiscale Simulations. Int. J. Mol. Sci. 2024, 25, 592. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms25010592](10.3390/ijms25010592)  \nAcademic Editor: Mauro Coluccia  \nReceived: 26 November 2023  \nRevised: 15 December 2023  \nAccepted: 16 December 2023  \nPublished: 2 January 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Al-Quwayiyah 19257, Saudi Arabia; [m.hakami@su.edu.sa](m.hakami@su.edu.sa)  \n2 Department of Pathology and Laboratory Medicine, Security Forces Hospital Program, Riyadh 11481, Saudi Arabia; [ahazazi@sfh.med.sa](ahazazi@sfh.med.sa) (A.H.); [falbloui@sfh.med.sa](falbloui@sfh.med.sa) (F.A.)  \n3 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University,  \nP.O. Box 11099, Taif 21944, Saudi Arabia; [amgharib@tu.edu.sa](amgharib@tu.edu.sa) (A.F.G.); [fouzeyyah@tu.edu.sa](fouzeyyah@tu.edu.sa) (F.A.A.); [o.osama@tu.edu.sa](o.osama@tu.edu.sa) (O.A.)  \n4 Pharmaceutical Practices Department, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia; [ayhazmi@uqu.edu.sa](ayhazmi@uqu.edu.sa)  \n* Correspondence: [ahadamer@tu.edu.sa](ahadamer@tu.edu.sa)  \nAbstract: Lung cancer is a pervasive and challenging disease with limited treatment options, with global health challenges often present with complex molecular profiles necessitating the exploration of innovative therapeutic strategies. Single-target drugs have shown limited success due to the heterogeneity of this disease. Multitargeted drug designing is imperative to combat this complexity by simultaneously targeting multiple target proteins and pathways, which can enhance treatment efficacy and overcome resistance by addressing the dynamic nature of the disease and stopping tumour growth and spread. In this study, we performed the molecular docking studies of Drug Bank compounds with a multitargeted approach against crucial proteins of lung cancer such as heat shock protein 5 (BIP/GRP78) ATPase, myosin 9B RhoGAP, EYA2 phosphatase inhibitor, RSK4 N-terminal kinase, and collapsin response mediator protein-1 (CRMP-1) using HTVS, SP with XP algorithms, and poses were filtered using MM\\GBSA which identified [3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1hIndol-5-Yloxy)-Propyl-]-Phosphonic Acid (3-1-BenCarMethIn YlPro-Phosphonic Acid) (DB02504) as multitargeted drug candidate with docking and MM\\GBSA score ranges from −5.83 to −10.66 and −7.56 to −50.14 Kcal/mol, respectively. Further, the pharmacokinetic and QM-based DFT studies have shown complete acceptance results, and interaction fingerprinting reveals that ILE, GLY, VAL, TYR, LEU, and GLN were among the most interacting residues. The 100 ns MD simulation in the SPC water model with NPT ensemble showed stable performance with deviation and fluctuations \u003C2 Å with huge interactions, making it a promising multitargeted drug candidate; however, experimental studies are needed before use.  \nKeywords: lung cancer; multitargeted drug designing; p","cbCainlO6zP5YfGO","https://ap.wps.com/l/cbCainlO6zP5YfGO","pdf",11124090,22,"English","# Abstract\n# Introduction","[{\"question\":\"Why is multitargeted drug design needed for lung cancer in this study?\",\"answer\":\"Single-target drugs have limited success because lung cancer is heterogeneous and resists one-size-fits-all treatments. Multitargeting aims to engage multiple proteins and pathways to improve efficacy and overcome resistance.\"},{\"question\":\"What computational methods were used to evaluate the candidate drug?\",\"answer\":\"The study used multitarget docking (HTVS and SP with XP algorithms), MM-GBSA scoring, pharmacokinetic assessment, and QM-based DFT studies, followed by interaction fingerprinting and 100 ns molecular dynamics simulation.\"},{\"question\":\"Which compound is reported as the multitargeted candidate?\",\"answer\":\"The compound identified as a multitargeted drug candidate is 3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1hIndol-5-Yloxy)-Propyl-]-Phosphonic Acid (3-1-BenCarMethIn YlPro-Phosphonic Acid), listed as DB02504.\"},{\"question\":\"What did the 100 ns MD simulation indicate about stability?\",\"answer\":\"In SPC water with an NPT ensemble, the simulation showed stable performance with deviation and fluctuations less than 2 Å, supported by strong interactions, suggesting promise for further development despite the need for experimental studies.\"}]","Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid’s Adroit Activity against Lung Cancer through Multitargeted Docking, MM-GBSA, QM-DFT and Multiscale Simulations | PDF",1790006666,55]